中新网广州9月29日电(刘烨岳佳综)记者29日从广东省物价局获悉，从10月8日起，该省将调整抗肿瘤、免疫和血液系统类等药品的最高零售价，共涉及95个品种、745个剂型规格，其中降幅最大的药品价格下调44.5%。

Beijing on September 29 - guangzhou(Liu ye YueJia heald)Reporters learned from 29, guangdong province bureau of commodity price,From October 8 day,The province will adjust antitumor/The immune and blood system drugs such as the highest retail price,Inoled a total of 95 varieties/745 dosage form specification,By the largest drug prices by 44.5%.

　　广东省物价局表示，此次价格调整，是在开展成本价格调查、专家评审和听取有关方面意见的基础上形成的。对日费用高的药品加大了降价力度、对日费用低的药品不降价，鼓励价格相对低廉药品的生产供应；对部分临床紧缺的血液制品适当提高了价格；对专利等创新型药品适当控制降价幅度，利用价格杠杆促进药品的研发创新；对原单独定价药品，进一步缩小了与统一定价药品之间的价差，以促进市场公平竞争。

Guangdong price bureau said,The price adjustment,Is in the development cost price survey/Expert review and listen to the opinions of the formed on the basis of.The high cost of drugs, to increase the price cut strength/To low cost, the drug is not depreciate,Encourage price are relatively cheap drugs production supply;For some clinical shortage of blood products appropriately raise the price;Such as patent innovative drug properly control the price range,Use the price lever to promote the pharmaceutical research and development innovation;The original single drug pricing,Further narrowed and unified pricing between drug price,In order to promote fair competition in the market.

　　参照上述原则和药品差比价规则，结合广东实际，广东省物价局对目前在广东市场销售的抗肿瘤、免疫和血液系统类等政府定价药品进行了全面清理，其中国家调整公布的200多个代表剂型规格，平均降价幅度为17%；广东公布的205个补充剂型规格，平均降价幅度为21.6%。

With reference to the above principles and drug differential ratio rule,Combined with the actual guangdong,Guangdong province bureau of commodity price on the market sales in guangdong anti-tumor/The immune and blood system such as the government pricing drug for a comprehensive cleaning,The state adjustment published more than 200 delegates dosage form specification,The average price cut of 17%;Guangdong published 205 supplementary dosage form specification,The average price cut of 21.6%.

　　此次公布的单独定价药品中，降幅最大的是重组人粒细胞集落刺激因子，从原来的216元调整为120元人民币，降幅达44.5%。

The official alone in drug pricing,Drop the largest is the recombinant human granulocyte colony stimulating factor,From the original 216 yuan to 120 yuan RMB,Drop of 44.5%.

　　广东省物价局表示，各医疗卫生机构、社会零售药店及其他药品生产经营单位销售相关药品的价格不得超过本次公布的价格。(完)

Guangdong price bureau said,The medical and health institutions/Social retail drugstores and other drug production and business operation entities related sales prices of medicines may not exceed the listed price.(finish)